Patient Centricity in Neurodegenerative diseases
Webinar Overview
Neurodegenerative Disorders are one of the most burdensome conditions on the planet not only for the patients, but also caregivers, health care providers, and the health care systems. Over the decades there has been a major focus to drive the science and research in the field, leading to better and more precise treatment options for the patients.
Nonetheless, there is a stronger need to incorporate patients' and carers' voices to inform each stage of value creation, from scientific discovery to providing access to new treatment options. This webinar brings experienced voices across the pharma industry and patient organizations to put a spotlight on where we stand on patient-centric approaches in clinical research for neurodegenerative disorders, and where we need to do more.
Who should attend
This webinar is designed for, drug developers, healthcare professionals, patient advocacy groups, and anyone interested in the advancement of neurodegenerative disease treatments.
What will you learn
- Patient-Centric Precision Medicine in Action: Fluid and Imaging Biomarkers for Patient Identification, Stratification and Monitoring Treatment Response
- Treatments for neurodegenerative disorders and the crucial role of biomarkers
- Why it is important to incorporate patient and caregiver input into the design and execution of neurodegenerative disease clinical trials
Speakers
Related insights
More from our insights
Elevate your neuromuscular clinical studies with Fortrea’s specialized expertise and comprehensive support
Download Article
Applying a patient- and site-centric approach in an early Phase I Alzheimer’s disease study
This case study discusses how Fortrea applied creative problem-solving to work though inherent challenges and shares a unique enrollment strategy for supporting sites and patients.
Téléchargez l'étude de cas
Enhancing endpoint protection in pain management clinical trials
Key considerations for endpoint protection in pain management clinical trials
En savoir plus
Parkinson’s disease: multiple ascending dose
Collaborative communication helped meet sponsor’s milestones and maintain patient safety
Téléchargez l'étude de cas
Promoting patient and site centricity in neurodegenerative disease clinical trials
Download White Paper
Phase I Alzheimer’s Disease
Applying a patient- and site-centric approach in an early Phase I Alzheimer’s Disease study
Téléchargez l'étude de cas
Importance of patient perspectives in neurology clinical trials
Incorporating patient perspectives through interviews in neurology clinical trials